GLAXO investors re-evaluating their investment strategy
24 May, 20197 min read
GLAXO performed worse than the broader market today. On a longer term basis, investors in GLAXOSMITHKLINE PHARMA LT made +0.02% per day. Friday's performance of +0.68% was a outperformance compared to it's daily average.
Want to improve your Portfolio's performance?
Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
Read analysis
Symbol
Price
{{retType}}
|
Tr.
{{detail.symbol}}
{{detail.close}}
{{detail.priceChange}}
{{detail.pctChange}}%
{{detail.name}}
{{detail.trend}}
Share with friends 
